
Harvard Bioscience HBIO
$ 5.39
-2.53%
Annual report 2025
added 03-13-2026
Harvard Bioscience Total Inventories 2011-2026 | HBIO
Annual Total Inventories Harvard Bioscience
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20.8 M | 23.2 M | 24.7 M | 26.4 M | 27.6 M | 22.3 M | 22.1 M | 25.1 M | 21.4 M | 20 M | 22.3 M | 20.5 M | 15.8 M | 17.8 M | 18.2 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 27.6 M | 15.8 M | 21.9 M |
Quarterly Total Inventories Harvard Bioscience
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21.6 M | 22.3 M | 22.8 M | 23.2 M | 26 M | 25.1 M | 24.1 M | 24.7 M | 25.8 M | 26.1 M | 26.9 M | 26.4 M | - | - | 28.7 M | 27.6 M | 26 M | 24.7 M | 22.7 M | 22.3 M | 22.3 M | 22.3 M | 22.3 M | 22.1 M | 22.1 M | 22.1 M | 22.1 M | 25.1 M | 25.1 M | 25.1 M | 25.1 M | 16.8 M | 16.8 M | 16.8 M | 16.8 M | 20 M | 20 M | 20 M | 20 M | 22.3 M | 22.3 M | 22.3 M | 22.3 M | 20.5 M | 20.5 M | 20.5 M | 20.5 M | 15.8 M | 15.8 M | 18.3 M | 15.8 M | 17.8 M | 17.8 M | 17.8 M | 17.8 M | 18.2 M | 18.2 M | 18.2 M | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 28.7 M | 15.8 M | 21.6 M |
Total Inventories of other stocks in the Medical instruments industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Baxter International
BAX
|
2.23 B | $ 16.57 | -0.48 % | $ 8.5 B | ||
|
Atrion Corporation
ATRI
|
82.3 M | - | - | $ 810 M | ||
|
The Cooper Companies
COO
|
846 M | $ 69.29 | -1.42 % | $ 13.8 B | ||
|
electroCore
ECOR
|
1.63 M | $ 6.94 | -1.41 % | $ 58.9 K | ||
|
Ekso Bionics Holdings
EKSO
|
4.82 M | $ 8.85 | -9.23 % | $ 21.5 M | ||
|
BioLife Solutions
BLFS
|
29 M | $ 18.86 | -2.13 % | $ 869 M | ||
|
AtriCure
ATRC
|
78.5 M | $ 29.19 | - | $ 1.39 B | ||
|
Glaukos Corporation
GKOS
|
42 M | $ 115.91 | -0.71 % | $ 5.61 B | ||
|
Haemonetics Corporation
HAE
|
365 M | $ 58.86 | 0.76 % | $ 2.96 B | ||
|
iRhythm Technologies
IRTC
|
21.6 M | $ 116.58 | -0.55 % | $ 3.73 B | ||
|
Repro Med Systems
KRMD
|
3.68 M | $ 4.26 | - | $ 197 M | ||
|
Masimo Corporation
MASI
|
459 M | $ 178.46 | -0.02 % | $ 9.51 B | ||
|
Microbot Medical
MBOT
|
584 K | $ 2.3 | -2.75 % | $ 105 M | ||
|
Milestone Scientific
MLSS
|
3.78 M | $ 0.29 | 1.48 % | $ 23.8 M | ||
|
Envista Holdings Corporation
NVST
|
288 M | $ 25.09 | -2.83 % | $ 4.22 B | ||
|
Pro-Dex
PDEX
|
22.2 M | $ 49.01 | 0.99 % | $ 161 M | ||
|
ResMed
RMD
|
744 M | $ 224.17 | -0.28 % | $ 32.7 B | ||
|
ICU Medical
ICUI
|
616 M | $ 122.22 | -0.63 % | $ 3.01 B | ||
|
Retractable Technologies
RVP
|
17.2 M | $ 0.69 | -3.18 % | $ 20.7 M | ||
|
InfuSystem Holdings
INFU
|
4.82 M | $ 9.46 | 0.21 % | $ 195 M | ||
|
Isoray
ISR
|
980 K | - | 0.03 % | $ 108 M | ||
|
Intuitive Surgical
ISRG
|
1.84 B | $ 450.42 | -0.48 % | $ 161 B | ||
|
STAAR Surgical Company
STAA
|
15.7 M | $ 21.39 | 2.05 % | $ 1.06 B | ||
|
Stereotaxis
STXS
|
9.57 M | $ 1.84 | -2.39 % | $ 167 M | ||
|
LeMaitre Vascular
LMAT
|
19.6 M | $ 109.9 | 0.67 % | $ 2.49 B | ||
|
Teleflex Incorporated
TFX
|
404 M | $ 115.57 | 0.42 % | $ 5.16 B | ||
|
Merit Medical Systems
MMSI
|
334 M | $ 67.4 | -0.6 % | $ 3.99 B | ||
|
Utah Medical Products
UTMD
|
7.94 M | $ 63.75 | 1.3 % | $ 207 M | ||
|
Predictive Oncology
POAI
|
481 K | - | - | $ 31.1 M | ||
|
Pulse Biosciences
PLSE
|
136 K | $ 19.84 | -13.51 % | $ 1.34 B | ||
|
West Pharmaceutical Services
WST
|
444 M | $ 258.17 | 0.47 % | $ 18.7 B | ||
|
DENTSPLY SIRONA
XRAY
|
642 M | $ 11.53 | -0.99 % | $ 2.3 B | ||
|
NeuroMetrix
NURO
|
1.35 M | - | 5.05 % | $ 9.02 M | ||
|
STERIS plc
STE
|
581 M | $ 219.59 | -0.18 % | $ 21.6 B | ||
|
AngioDynamics
ANGO
|
62 M | $ 9.52 | -3.25 % | $ 389 M | ||
|
Becton, Dickinson and Company
BDX
|
3.89 B | $ 155.08 | -0.1 % | $ 44.6 B | ||
|
Nephros
NEPH
|
2.47 M | $ 2.66 | -6.89 % | $ 27.6 M | ||
|
OraSure Technologies
OSUR
|
31.1 M | $ 3.03 | -1.62 % | $ 223 M | ||
|
Repligen Corporation
RGEN
|
202 M | $ 114.47 | -2.12 % | $ 6.38 M |